HomeCRNX • NASDAQ
Crinetics Pharmaceuticals Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 361.00K | -43.59% |
Operating expense | 35.53M | 70.57% |
Net income | -96.77M | -44.59% |
Net profit margin | -26.81K | -156.34% |
Earnings per share | -1.04 | -11.83% |
EBITDA | -110.48M | -51.23% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.27B | 41.42% |
Total assets | 1.36B | 39.17% |
Total liabilities | 107.33M | 3.98% |
Total equity | 1.25B | — |
Shares outstanding | 93.68M | — |
Price to book | 2.33 | — |
Return on assets | -19.92% | — |
Return on capital | -20.77% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -96.77M | -44.59% |
Cash from operations | -88.45M | -67.35% |
Cash from investing | -85.96M | -27,919.09% |
Cash from financing | 4.44M | -98.87% |
Net change in cash | -169.98M | -149.84% |
Free cash flow | -47.18M | -69.57% |
Previous close
$31.21
Day range
$30.89 - $31.80
Year range
$24.10 - $62.53
Market cap
2.91B USD
Avg Volume
984.67K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
Nov 18, 2008
Website
Employees
437
